Tango Therapeutics Inc【TNGX】株式ニュース

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Form 8-K - Current report

Tango Therapeutics Appoints Robert Azelby to Board of Directors

BOSTON, June 22, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage...

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering

BOSTON, June 09, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (“Tango”) (Nasdaq: TNGX), a clinical-stage...

Form 4 - Statement of changes in beneficial ownership of securities

Form 424B5 - Prospectus [Rule 424(b)(5)]

Tango Therapeutics Announces Proposed $500 Million Public Offering

BOSTON, June 08, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (“Tango”) (Nasdaq: TNGX), a clinical-stage...

Form 8-K - Current report

Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

Initial data from ongoing Phase 1/2 trial in patients with second and third line PDAC treated with vopimetostat...

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, June 05, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

glenn1919 1年前

TNGX......................................................https://stockcharts.com/h-sc/ui?s=TNGX&p=W&b=5&g=0&id=p86431144783

👍️0

glenn1919 1年前

TNGX.........................................https://stockcharts.com/h-sc/ui?s=TNGX&p=W&b=5&g=0&id=p86431144783

👍️0

ollik78 1年前

Let's break 3$ tomorrow

👍️0

Monksdream 1年前

TGNX off the mat
https://api.wsj.net/api/kaavio/charts/big.chart?nosettings=1&symb=TNGX&uf=0&type=2&size=2&sid=206390187&style=320&freq=1&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=8&rand=682776204&compidx=&ma=0&maval=9&lf=1&lf2=0&lf3=0&height=335&width=579&mocktick=1

👍️0

makinezmoney 1年前

$TNGX: Now 2.50............. supppppppppppppppp

Another winner

How about that

GO $TGNX

👍️0

makinezmoney 1年前

$TNGX: Broke out of $2 flag......... boosting now

Now at $2.18

That was a nice TA breakout there.

GO $TNGX

👍️0

glenn1919 1年前

TNGX...........................https://stockcharts.com/h-sc/ui?s=TNGX&p=W&b=5&g=0&id=p86431144783

TNGX, recent 52 week lows

Stopped out with small loss.

👍️0

bikaver 3年前

TNGX......Holding up well, but will tumble soon.

👍️0

bikaver 3年前

TNGA.....short @ 8.60 This is the strength that I wanted to see!

👍️0

bikaver 3年前

TNGX.....Studying the TNGX chart this evening. I'll short it at a good sign of strength if the opportunity presents itself tomorrow.

👍️0

SmokeSignals 3年前

up $4>H.C. Wainwright Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
Barclays Releases a Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
Goldman Sachs Keeps Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 7, 2023TIPRANKS
Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business HighlightsAUGUST 7, 2023TIPRANKS
Tango Therapeutics reports Q2 EPS (23c), consensus (34c)AUGUST 7, 2023TIPRANKS

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Tango Therapeutics Inc (TNGX)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

Tango Therapeutics Inc (TNGX) ニュース

Form 8-K - Current report

Tango Therapeutics Appoints Robert Azelby to Board of Directors

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 424B5 - Prospectus [Rule 424(b)(5)]

Tango Therapeutics Announces Proposed $500 Million Public Offering

Form 8-K - Current report

Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

TNGX Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Tango Therapeutics Inc (TNGX)

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

Tango Therapeutics Inc (TNGX) ニュース

Form 8-K - Current report

Tango Therapeutics Appoints Robert Azelby to Board of Directors

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 424B5 - Prospectus [Rule 424(b)(5)]

Tango Therapeutics Announces Proposed $500 Million Public Offering

Form 8-K - Current report

Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

TNGX Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する